Reduced Circulating HIF‐1α, HIF‐2α, HIF‐3α, and VHL Levels in Patients With Pulmonary Arterial Hypertension

Documenti analoghi

• Prophylactic Effects of Radiofrequency Electromagnetic Field on Pulmonary Ischemia‐Reperfusion via HIF‐1α/eNOS Pathway and BCL2/BAX Signaling
  di: Süleyman Emre Akin, et al.
  Pubblicazione: (2025)
• Prevalence and Economic Burden of Pulmonary Hypertension and Pulmonary Arterial Hypertension Among the Medicaid Population
  di: Marshaleen Henriques King, et al.
  Pubblicazione: (2025)
• Flow Cytometric Determination of Circulating Progenitor Cells in Patients With Pulmonary Arterial Hypertension: A Systematic Review
  di: Kimia Heydari, et al.
  Pubblicazione: (2025)
• Prognostic Role of Platelets in Pulmonary Arterial Hypertension
  di: Caio Julio Cesar dos Santos Fernandes, et al.
  Pubblicazione: (2025)
• Heart Rate Variability in Pulmonary Arterial Hypertension
  di: Bishal Gyawali, et al.
  Pubblicazione: (2025)